VRXA is trading 6.8% up at $3.23, extending a multi-day rally following its recent Nasdaq debut and updates regarding its lead development program.

  • Shares have been climbing as investors digest the June 10 public listing via a business combination with Voyager Acquisition Corp.
  • Recent corporate updates highlighted the company's partnering strategy and development timelines, alongside news of cell line development to advance its lead BiTAC-TCE program.